The global newborn screening market, by Product Type (Assay Kits, Hearing Screening Devices, Mass Spectrometer, and Pulse Oximetry), by Application (Blood Spot Disease, Critical Congenital Cardiac Disease, Maple Syrup Urine Disease, Hearing Disability, Sickle Cell Disease, and Thyroid Disorder), by Test (Blood Test, Cardiac Test, Hearing Test, and Urine Test), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 1,412.2 Mn in 2021, and is projected to exhibit a CAGR of 10.5% over the forecast period (2021-2028).
Request for Analysis of COVID-19 Impact on New Born Screening Market – https://www.coherentmarketinsights.com/insight/request-sample/2192
Newborn screening tests look for developmental, metabolic, and genetic disorders in infants. A majority of these illnesses are very rare, they can be treated with early diagnosis. Newborn screening involves tests of around 30 conditions and illnesses. Increasing awareness among parents for disease screening is a major factor driving newborn screening market growth. In addition, various government and non-government organizations are actively focused on offering better fetal and maternal care.
In June 2018, the American Society of Hematology (ASH) led a campaign to fight sickle cell disease in Africa and urged governments in the region to invest in newborn screening of the disease. A multitude of treatments, new biomarkers and technologies are expected to enable various diseases to be considered as potential candidates to be included in New Born Screening (NBS) programs. For instance, new treatments such as Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and gene therapy, as well as new pharmacological drugs, have allowed autoimmune diseases to be regarded as potential candidates for several NBS programs.
The key market players are majorly focused on the development of novel test kits and devices in order to diagnose more diseases or disorders at birth. In February 2018, Sema4 launched Sema4 Natalis, a supplemental newborn screening test designed to detect 193 childhood-onset diseases or disorders. Also, various governments around the world are supporting manufacturers to develop new screening tests by relaxing regulations for manufacturing and marketing products.
In February 2017, the U.S. FDA approved marketing of the Seeker System for the screening of four, rare Lysosomal Storage Disorders (LSDs) in newborns. The system is designed to detect Fabry, Gaucher, Mucopolysaccharidosis Type I (MPS I), and Pompe.
View Press Release For More Information
Key Market Takeaways:
- According to the National Institute of Health, NBS programs across the U.S. are known to screen around four million infants annually. This public health program detects treatable disorders in newborns, allowing treatment to begin often before symptoms or permanent problems occur.
- Among the various product types, the assay kits segment is projected to account for a major revenue share in 2018, owing to the escalating number of blood tests being conducted worldwide.
- The notable players operating in the global newborn screening market include Agilent Technologies, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc., and ZenTech S.A.
Buy Now this Premium Report to Grow your Business: https://www.coherentmarketinsights.com/insight/buy-now/2192
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Test Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Government Issues
- Product Recalls
- Regulatory Scenario
- Market Trends
- New Product Launches
- Collaboration, Partnership, Agreement, Merger and Acquisition
- Novel Technologies
- Epidemiology
- PEST Analysis
- Porters Five Forces Analysis
- Market Dynamics
- Global New Born Screening Market– Impact of Coronavirus (COVID-19) Pandemic
- Supply side and demand side analysis
- COVID-19 impact on overall healthcare market
- Global New Born Screening Market, By Product, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Assay Kits and Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global New Born Screening Market, By Test Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Dry Blood Spot Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Cardiac Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Hearing Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Urine test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global New Born Screening Market, By Application, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Phenylketonuria (PKU)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Critical Congenital Heart Defect
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Maple Syrup Urine Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Hearing Disability
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Sickle Cell Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn Others
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn
- Introduction
- Global New Born Screening Market, By End User, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Maternity and Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global New Born Screening Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Section
- Research Methodology
- About us
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837